Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Randomised Double-Blinded Placebo-Controlled Study of Use of GnRHa During Chemotherapy for Fertility Protection of Young Women and Teenagers With Cancer

NCT05328258 is registered in ClinicalTrials.gov with Kenny Rodriguez-Wallberg as lead sponsor.

NCT NCT05328258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05328258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Randomised Double-Blinded Placebo-Controlled Study of Use of GnRHa During Chemotherapy for Fertility Protection of Young Women and Teenagers With Cancer
Lead sponsor
Kenny Rodriguez-Wallberg
Phase
Phase 3
Overall status
Recruiting
Start date
March 31, 2023
Completion date
January 31, 2032
Enrollment
500 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, breast cancer female, ewing sarcoma, lymphoma, osteosarcoma, soft tissue sarcoma